Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2010
Total Assets: $195.01B
Liabilities Breakdown FY2010
Total Liabilities: $106.75B
Asset Breakdown
Total Assets: $195.01B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.74B | 0.9% |
| Accounts Receivable | $13.38B | 6.9% |
| Inventory | $8.28B | 4.2% |
| Property, Plant & Equipment | $17.61B | 9.0% |
| Goodwill | $43.43B | 22.3% |
| Intangible Assets | $57.56B | 29.5% |
| Other Assets | $53.03B | 27.2% |
Liabilities Breakdown
Total Liabilities: $106.75B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.99B | 3.7% |
| Long-Term Debt | $38.41B | 36.0% |
| Other Liabilities | $64.35B | 60.3% |